Cargando…

Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo

Detalles Bibliográficos
Autores principales: Dufresne, AL, Fu, D, Ambinder, RF
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261768/
http://dx.doi.org/10.1186/1750-9378-4-S2-P16
_version_ 1782348324249010176
author Dufresne, AL
Fu, D
Ambinder, RF
author_facet Dufresne, AL
Fu, D
Ambinder, RF
author_sort Dufresne, AL
collection PubMed
description
format Online
Article
Text
id pubmed-4261768
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42617682014-12-10 Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo Dufresne, AL Fu, D Ambinder, RF Infect Agent Cancer Poster Presentation BioMed Central 2009-06-17 /pmc/articles/PMC4261768/ http://dx.doi.org/10.1186/1750-9378-4-S2-P16 Text en Copyright © 2009 Dufresne et al; licensee BioMed Central Ltd.
spellingShingle Poster Presentation
Dufresne, AL
Fu, D
Ambinder, RF
Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
title Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
title_full Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
title_fullStr Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
title_full_unstemmed Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
title_short Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
title_sort burkitt's lymphoma: differential killing of epstein-barr virus (ebv) (+) and ebv(-) burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261768/
http://dx.doi.org/10.1186/1750-9378-4-S2-P16
work_keys_str_mv AT dufresneal burkittslymphomadifferentialkillingofepsteinbarrvirusebvandebvburkittlymphomacellsinvitroanddosedependentlyticinductionbybortezomibinvivo
AT fud burkittslymphomadifferentialkillingofepsteinbarrvirusebvandebvburkittlymphomacellsinvitroanddosedependentlyticinductionbybortezomibinvivo
AT ambinderrf burkittslymphomadifferentialkillingofepsteinbarrvirusebvandebvburkittlymphomacellsinvitroanddosedependentlyticinductionbybortezomibinvivo